Telomir Pharmaceuticals, Inc. Common Stock (TELO) Earnings Dates & History
NASDAQ·Healthcare·Biotechnology
$0.73
-6.72%
Mkt Cap $45.04M
EPS — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 17, 2026 | — | — | — | -$0.07 | -$0.06 | +14.29% |
| Q4 2025 Nov 10, 2025 | — | — | — | -$0.07 | -$0.03 | +57.14% |
| Q3 2025 Aug 14, 2025 | — | — | — | -$0.08 | -$0.17 | -112.50% |
| Q2 2025 May 14, 2025 | — | — | — | -$0.10 | -$0.07 | +30.00% |
| Q1 2025 Feb 4, 2025 | — | $18.79M | — | -$0.05 | -$0.10 | -100.00% |
| Q4 2024 Nov 12, 2024 | — | — | — | -$0.05 | -$0.20 | -300.00% |
| Q3 2024 Aug 13, 2024 | — | — | — | — | -$0.05 | — |
| Q2 2024 May 13, 2024 | — | — | — | — | -$0.23 | — |
| Q1 2024 Mar 29, 2024 | — | — | — | — | -$0.32 | — |
| Q3 2023 Sep 30, 2023 | — | — | — | — | -$0.06 | — |
| Q2 2023 Jun 30, 2023 | — | — | — | — | -$0.05 | — |
| Q1 2023 Mar 31, 2023 | — | — | — | — | -$0.02 | — |
| Q4 2022 Dec 31, 2022 | — | — | — | — | -$0.02 | — |
| Q3 2022 Sep 29, 2022 | — | — | — | — | -$0.01 | — |
| Q2 2022 Jun 29, 2022 | — | — | — | — | -$0.00 | — |
| Q1 2022 Mar 31, 2022 | — | — | — | — | -$0.00 | — |